{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:04:57Z","timestamp":1778227497493,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ygyno.2013.10.029","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T17:53:35Z","timestamp":1383242015000},"page":"70-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: A multicenter review of 114 cases"],"prefix":"10.1016","volume":"132","author":[{"given":"Aera","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Yeol","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chel Hun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duk-Soo","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung-Gie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo-Hyun","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.10.029_bb0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: a review","volume":"116","author":"D'Angelo","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0010","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/1097-0142(196606)19:6<755::AID-CNCR2820190604>3.0.CO;2-U","article-title":"Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors","volume":"19","author":"Norris","year":"1966","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.critrevonc.2007.06.011","article-title":"The management of patients with uterine sarcoma: a debated clinical challenge","volume":"65","author":"Gadducci","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1477-7819-4-50","article-title":"Low grade endometrial stromal sarcoma of uterine corpus, a clinico-pathological and survey study in 14 cases","volume":"4","author":"Ashraf-Ganjoei","year":"2006","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0025","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/annonc\/mdq064","article-title":"Impact of adjuvant treatment modalities on the management of patients with stages I\u2013II endometrial stromal sarcoma","volume":"21","author":"Malouf","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2011.10.010","article-title":"Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment","volume":"125","author":"Beck","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"Suppl. 10","key":"10.1016\/j.ygyno.2013.10.029_bb0035","doi-asserted-by":"crossref","first-page":"x151","DOI":"10.1093\/annonc\/mds359","article-title":"The treatment of uterine sarcomas","volume":"23","author":"Reichardt","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0040","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/01.AOG.0000185511.91694.1e","article-title":"Ovarian preservation in stage I low-grade endometrial stromal sarcomas","volume":"106","author":"Li","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0045","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0090-8258(03)00258-0","article-title":"Low-grade endometrial stromal sarcoma: hormonal aspects","volume":"90","author":"Chu","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2010.04.008","article-title":"Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?","volume":"118","author":"Garg","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0055","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ygyno.2012.11.009","article-title":"Old versus new FIGO staging systems in predicting overall survival in patients with uterine leiomyosarcoma: a study of 86 cases","volume":"128","author":"Lim","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0060","series-title":"Pathology and genetics of tumours of the breast and female genital organs","author":"Tavassoli","year":"2003"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijgo.2008.12.008","article-title":"FIGO staging for uterine sarcomas","volume":"104","author":"Prat","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0070","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijgo.2009.04.002","article-title":"Corrigendum to \u201cFIGO staging for uterine sarcomas\u201d","volume":"106","author":"Oncology FCOG","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0075","first-page":"1363","article-title":"Lymphadenectomy in uterine low-grade endometrial stromal sarcoma: an analysis of 19 cases and a literature review","volume":"20","author":"Signorelli","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0080","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/AOG.0b013e31818aa89a","article-title":"Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma","volume":"112","author":"Shah","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0085","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/sj.bjc.6604527","article-title":"Endometrial stromal sarcoma: a population-based analysis","volume":"99","author":"Chan","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0090","doi-asserted-by":"crossref","first-page":"e757","DOI":"10.1016\/j.ijrobp.2011.11.005","article-title":"Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study","volume":"82","author":"Schick","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0095","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2559.2011.04115.x","article-title":"Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma","volume":"62","author":"Feng","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0100","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ygyno.2007.10.023","article-title":"Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases","volume":"108","author":"Li","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/CCO.0b013e3281a7ef3a","article-title":"Hormonal therapy of endometrial stromal sarcoma","volume":"19","author":"Reich","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0110","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1210\/jc.2010-1746","article-title":"Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period","volume":"96","author":"Randolph","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0115","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/gme.0b013e31824d8f40","article-title":"Executive summary of the stages of reproductive aging workshop+10: addressing the unfinished agenda of staging reproductive aging","volume":"19","author":"Harlow","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-8258(03)00207-5","article-title":"The diagnostic problem of endometrial stromal sarcoma: report on six cases","volume":"90","author":"Amant","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0125","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ygyno.2009.08.014","article-title":"Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles","volume":"115","author":"Ioffe","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s13277-010-0138-1","article-title":"Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers","volume":"32","author":"Koivisto-Korander","year":"2011","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ygyno.2010.12.360","article-title":"Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy","volume":"121","author":"Cheng","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0140","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1054\/bjoc.1999.1038","article-title":"Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas","volume":"82","author":"Reich","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejogrb.2009.02.005","article-title":"The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study","volume":"144","author":"Dahhan","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0150","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3109\/01443610903165552","article-title":"Hormonal therapy with letrozole prior to surgical management of recurrent metastatic low-grade endometrial stromal sarcoma (LGESS)","volume":"29","author":"Tzakas","year":"2009","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2013.10.029_bb0155","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/IGC.0b013e31825b7de8","article-title":"Uterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature","volume":"22","author":"Altman","year":"2012","journal-title":"Int J Gynecol Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581301278X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581301278X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T17:16:12Z","timestamp":1564593372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581301278X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S009082581301278X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.10.029","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: A multicenter review of 114 cases","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}